News

Fraud-prevention software developer Adveritas (ASX: AV1) has completed an $8.5 million placement to existing shareholders and new institutional investors ...
Amplia Therapeutics (ASX: ATX) continues to make excellent progress with focal adhesion kinase (FAK) inhibitor narmafotinib, ...
Sprintex (ASX: SIX) has secured a $377,000 order from Türkish distributor Net 0 Enerji for the supply of high-capacity G ...
Bioxyne (ASX: BXN) has received certificates of Good Manufacturing Practice (GMP) compliance under mutual recognition ...
INOVIQ (ASX: IIQ) has reported superior efficacy from an in vitro study of CAR-exosomes cancer therapy that killed almost 88% ...
European Lithium (ASX: EUR) has welcomed news that the Tanbreez rare earth project in Greenland has received a Letter of ...
Resolution Minerals (ASX: RML) has brought in a Washington-based specialist to support its aims to obtain US government ...